Andere talen Tianda Pharmaceuticals Limited

Aandelen

455 KYG887471038

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:20 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,265 ^HKD	+3,92%		+1,92%	+21,56%

26/03	Tianda Pharmaceuticals Limited stelt slotdividend voor voor het jaar eindigend op 31 december 2023	CI
26/03	Tianda Pharmaceuticals Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Tianda Pharmaceuticals Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024	26/03
Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023	21/03
Tianda Pharmaceuticals Limited Announces Executive Changes, Effective 29 August 2023	28-08-23
Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2023	28-08-23
Tianda Pharmaceuticals to Shrink H1 Loss by Over 70%	24-08-23
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Interim Period Ended June 30, 2023	23-08-23
Tianda Unit Buys Out 45% Stake in Meng Sheng Pharmaceutical	02-08-23
Tianda Pharmaceuticals Limited entered into an equity transfer agreement to acquire 45% stake in Yunnan Mengsheng Pharmaceutical Co., Ltd from Yunnan Linuo Biotechnology Co., Ltd. for HKD 23.5 million.	01-08-23
Tianda Pharmaceuticals Limited Announces Board Changes	27-06-23
Tianda Pharmaceuticals Limited Approves Final Dividend	27-06-23
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Nine Months Ended 31 December 2022, Payable on or Before, 14 July 2023	19-05-23
Tianda Pharmaceuticals Unit to Invest HK$10 Million in Fund	19-04-23
Beijing Tong Ren Tang Chinese Medicine’s CEO Redesignated; New CEO Named	19-04-23
Tianda Pharmaceuticals Limited Announces Final Ordinary Dividend for the Nine Months Ended 31 December 2023	23-03-23
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022	23-03-23
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022	23-03-23
Tianda Pharmaceuticals Warns of Higher Loss in Fiscal Nine-Month Period; Shares Tumble 9%	20-03-23
Tianda Pharmaceuticals Limited Provides Group Earnings Guidance for the Nine Months Period from April 1, 2022 to December 31, 2022	19-03-23
Tianda Pharmaceuticals to Set Up Additional Production Line to Meet Rising Medicine Demand	19-12-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Tianda Pharmaceuticals Limited

Aandelen

455

KYG887471038

Andere talen

Filters